Mirae Asset Global Investments Co. Ltd. Has $10.53 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Mirae Asset Global Investments Co. Ltd. raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 20.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 114,420 shares of the company's stock after acquiring an additional 19,609 shares during the quarter. Mirae Asset Global Investments Co. Ltd.'s holdings in GE HealthCare Technologies were worth $10,525,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in GEHC. Pathway Financial Advisers LLC acquired a new position in GE HealthCare Technologies in the first quarter worth $25,000. Fred Alger Management LLC bought a new position in GE HealthCare Technologies in the second quarter worth about $26,000. BNP Paribas acquired a new position in GE HealthCare Technologies in the first quarter valued at approximately $30,000. Elkhorn Partners Limited Partnership bought a new position in shares of GE HealthCare Technologies during the second quarter valued at approximately $31,000. Finally, ORG Partners LLC raised its position in shares of GE HealthCare Technologies by 2,475.0% during the 2nd quarter. ORG Partners LLC now owns 412 shares of the company's stock worth $32,000 after purchasing an additional 396 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 2.8 %

Shares of GEHC stock traded down $2.49 on Monday, reaching $85.93. 4,223,017 shares of the company's stock traded hands, compared to its average volume of 2,997,618. The company has a market capitalization of $39.22 billion, a P/E ratio of 25.13, a price-to-earnings-growth ratio of 3.34 and a beta of 1.18. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.55. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The business's 50 day moving average price is $88.43 and its two-hundred day moving average price is $83.40.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last issued its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating analysts' consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter in the prior year, the company earned $0.92 EPS. The firm's quarterly revenue was up .5% on a year-over-year basis. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.03 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.14%. GE HealthCare Technologies's dividend payout ratio is 3.51%.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. UBS Group lowered GE HealthCare Technologies from a "neutral" rating to a "sell" rating and reduced their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Evercore ISI increased their price objective on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an "outperform" rating in a report on Tuesday, October 1st. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a research note on Monday, September 9th. They set a "neutral" rating and a $90.00 target price for the company. Stifel Nicolaus raised their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a "buy" rating in a research note on Monday, September 30th. Finally, BTIG Research upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price objective for the company in a research report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $94.23.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company's stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the transaction, the chief executive officer now directly owns 17,509 shares of the company's stock, valued at $1,414,377.02. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.27% of the company's stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.